111 (YI) Liabilities and Shareholders Equity (2017 - 2025)
111 (YI) reported Liabilities and Shareholders Equity of $310.2 million for Q4 2025, down 20.07% on a YoY basis from $388.1 million in Q4 2024, and down 10.56% sequentially from $346.8 million in Q3 2025.
111 (YI) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends
111 (YI) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $310.2 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 20.07% year-over-year to $310.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 36.69% YoY), and the FY2025 full-year result was $306.2 million, down 19.83% from the prior year.
- Liabilities and Shareholders Equity eased to $310.2 million in Q4 2025, from $346.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $510.7 million in Q2 2021 to a low of $342381.4 in Q2 2025.
- A 5-year average of $336.8 million and a median of $409.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity jumped 92171.55% in 2022 and tumbled 99.91% in 2025, its largest moves.
- Tracing YI's Liabilities and Shareholders Equity over 5 years: stood at $492.0 million in 2021, then declined by 0.73% to $488.4 million in 2022, then fell by 12.16% to $429.0 million in 2023, then declined by 9.54% to $388.1 million in 2024, then dropped by 20.07% to $310.2 million in 2025.
- Business Quant data shows YI's Liabilities and Shareholders Equity at $310.2 million in Q4 2025, $346.8 million in Q3 2025, and $342381.4 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 82.32 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 81.65 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 56.69 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 11.30 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 189.63 Mn |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 310.22 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.42 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 72.06 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 2.31 Mn |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 62.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 310.22 Mn |
| Sep 30, 2025 | 346.83 Mn |
| Jun 30, 2025 | 342,381.38 |
| Mar 31, 2025 | 358.76 Mn |
| Dec 31, 2024 | 388.10 Mn |
| Sep 30, 2024 | 422.73 Mn |
| Jun 30, 2024 | 385.29 Mn |
| Mar 31, 2024 | 408.99 Mn |
| Dec 31, 2023 | 429.03 Mn |
| Sep 30, 2023 | 464.65 Mn |
| Jun 30, 2023 | 435,486.50 |
| Mar 31, 2023 | 473,427.19 |
| Dec 31, 2022 | 488.43 Mn |
| Sep 30, 2022 | 446.64 Mn |
| Jun 30, 2022 | 470.70 Mn |
| Dec 31, 2021 | 492.04 Mn |
| Sep 30, 2021 | 484,046.99 |
| Jun 30, 2021 | 510.70 Mn |
| Mar 31, 2021 | 475.05 Mn |
| Dec 31, 2020 | 456.68 Mn |